The Company’s business has a double origin of, on the one hand, the collection, processing, and shipping of biospecimen, mostly for companies active in diagnostics research and, on the other hand, data image annotation for companies active in medical diagnostics machine learning research.
This rather unique and highly specialised background made us aware of the increasing need of the rapidly growing AI- assisted medical diagnostics industry for medical data of the right quality and with the appropriate metadata. Annotation of such data is also increasingly required.
The founder created a biospecimen CRO in 2009 that specialized in originating and processing a wide range of bio-specimen for international pharmaceutical and medical diagnostics research companies.
Bio-specimen often included basic clinical data , along with redacted pathology reports and additional data generated by genomic, and histopathology services. Initially, most of the biospecimen originated from Ukrainian clinics but more recently, biospecimen were collected more widely. The company was acquired in 2020 by a leading life sciences company in the USA.
In 2015, the founder also co-founded a data annotation company that initially worked mostly for the automotive industry , but rapidly grew to service a range of other industries including retail, agribusiness and FMCG industries.
Over the past 20 years, Martin has been a serial start-up entrepreneur (co-) founding a number of businesses in B2B, financial services, data annotation for machine learning and a medical CRO.
Martin always believed that a strict corporate governance framework is a prerequisite to creating company value. This is even more true in today’s complex international environment with ever-increasing IP and data security requirements.
Following four successful exits, Martin founded medDARE, responding to the rapidly increasing need for original high-quality raw and annotated medical data to support organizations around the world to meet their research and development objectives.
We understand the needs of research teams in terms of quality and the absolute need to ensure the highest levels of data security and corporate governance. At medDARE, we strive to combine the highest levels of quality and safety of our data. Full compliance with data privacy regulations is obvious to us.